Does IgE Have a Role in Aspirin-exacerbated Respiratory Disease?

被引:9
作者
Busse, William W. [1 ]
机构
[1] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA
关键词
OMALIZUMAB;
D O I
10.1164/rccm.202003-0783ED
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:1459 / 1460
页数:3
相关论文
共 11 条
[1]   Aspirin sensitivity: Lessons in the regulation (and dysregulation) of mast cell function [J].
Boyce, Joshua A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (04) :875-881
[2]   Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease [J].
Cahill, Katherine N. ;
Bensko, Jillian C. ;
Boyce, Joshua A. ;
Laidlaw, Tanya M. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (01) :245-252
[3]   Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy A Randomized Trial [J].
Hanania, Nicola A. ;
Alpan, Oral ;
Hamilos, Daniel L. ;
Condemi, John J. ;
Reyes-Rivera, Irmarie ;
Zhu, Jin ;
Rosen, Karin E. ;
Eisner, Mark D. ;
Wong, Dennis A. ;
Busse, William .
ANNALS OF INTERNAL MEDICINE, 2011, 154 (09) :573-582
[4]   Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease A Randomized Controlled Trial [J].
Hayashi, Hiroaki ;
Fukutomi, Yuma ;
Mitsui, Chihiro ;
Kajiwara, Keiichi ;
Watai, Kentaro ;
Kamide, Yosuke ;
Nakamura, Yuto ;
Hamada, Yuto ;
Tomita, Yasuhiro ;
Sekiya, Kiyoshi ;
Tsuburai, Takahiro ;
Izuhara, Kenji ;
Wakahara, Keiko ;
Hashimoto, Naozumi ;
Hasegawa, Yoshinori ;
Taniguchi, Masami .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (12) :1488-1498
[5]   Omalizumab reduces cysteinyl leukotriene and 9α,11β-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease [J].
Hayashi, Hiroaki ;
Mitsui, Chihiro ;
Nakatani, Eiji ;
Fukutomi, Yuma ;
Kajiwara, Keiichi ;
Watai, Kentaro ;
Sekiya, Kiyoshi ;
Tsuburai, Takahiro ;
Akiyama, Kazuo ;
Hasegawa, Yoshinori ;
Taniguchi, Masami .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (05) :1585-1587
[6]   Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)a EAACI position paper [J].
Kowalski, Marek L. ;
Agache, Ioana ;
Bavbek, Sevim ;
Bakirtas, Arzu ;
Blanca, Miguel ;
Bochenek, Grazyna ;
Bonini, Matteo ;
Heffler, Enrico ;
Klimek, Ludger ;
Laidlaw, Tanya M. ;
Mullol, Joaquim ;
Nizankowska-Mogilnicka, Ewa ;
Park, Hae-Sim ;
Sanak, Marek ;
Sanchez-Borges, Mario ;
Sanchez-Garcia, Silvia ;
Scadding, Glenis ;
Taniguchi, Masami ;
Torres, Maria J. ;
White, Andrew A. ;
Wardzynska, Aleksandra .
ALLERGY, 2019, 74 (01) :28-39
[7]   Aspirin-Exacerbated Respiratory Disease - New Prime Suspects [J].
Laidlaw, Tanya M. ;
Boyce, Joshua A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (05) :484-488
[8]   Omalizumab can inhibit respiratory reaction during aspirin desensitization [J].
Lang, David M. ;
Aronica, Mark A. ;
Maierson, Elizabeth S. ;
Wang, Xiao-Feng ;
Vasas, Dorothy C. ;
Hazen, Stanley L. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (01) :98-104
[9]  
MacGlashan DW, 1997, J IMMUNOL, V158, P1438
[10]   Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria [J].
Maurer, Marcus ;
Rosen, Karin ;
Hsieh, Hsin-Ju ;
Saini, Sarbjit ;
Grattan, Clive ;
Gimenez-Arnau, Ana ;
Agarwal, Sunil ;
Doyle, Ramona ;
Canvin, Janice ;
Kaplan, Allen ;
Casale, Thomas .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (10) :924-935